Holy Basil (Tulsi) for Anti-Inflammatory

Research suggests that Holy Basil (Tulsi, Ocimum sanctum) possesses meaningful anti-inflammatory properties, with evidence spanning laboratory studies, animal models, and a smaller number of human clinical investigations, all generally pointing in a supportive direction. Studies indicate that key bioactive compounds — particularly eugenol, ursolic acid, rosmarinic acid, and various flavonoids — appear to drive these effects through mechanisms such as free radical scavenging, nitric oxide inhibition, protein denaturation suppression, and modulation of immune responses, with potential relevance to conditions ranging from periodontitis and oral inflammation to neuroinflammation associated with Alzheimer's and Parkinson's disease. The available human clinical evidence, including small trials examining Tulsi gel for gingivitis and periodontal disease, does show promising results, and a 2017 systematic review of 24 human studies found broadly favorable outcomes with no significant adverse events reported. However, the body of evidence remains heavily weighted toward preclinical and review-level research, with most authors consistently noting the need for larger, well-controlled clinical trials to establish optimal formulations, dosing, and the populations most likely to benefit.